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114a Sunday, March 6, 2011transition from the active state to the intermediate state. In the absence of cal-
cium the rapid decrease in fluorescence was followed by a slower fluorescence
increase as the inactive state became populated. Acrylodan labeled smooth
muscle tropomyosin behaved much like labeled skeletal muscle tropomyosin
(Borrego-Diaz & Chalovich, 2010). When the same experiment was done
with acrylodan labeled tropomyosin-actin-caldesmon a similar pattern of fluo-
rescence decrease and increase occurred. The rapid decrease corresponded to
movement to the intermediate state and could not be distinguished from the
rate of S1-ATP detachment. The slower redevelopment of fluorescence differed
from the case with troponin in that it occurred as caldesmon binding increased
to occupy sites vacated by S1. Changes in caldesmon binding were monitored
by NBD probes on caldesmon. We sometimes observed an increase in acrylo-
dan fluorescence when caldesmon was mixed with acrylodan-tropomyosin
alone. Thus in the case of caldesmon, S1-ATP detachment occurs with a rapid
fluorescence decrease that was independent of caldesmon. The slow fluores-
cence redevelopment occurred as caldesmon bound to actin-tropomyosin. We
have not determined if in that case the fluorescence change coincided with
tropomyosin movement.
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Cardiac Troponin T: A Sarcomeric AKAP, Tethers Protein Kinase a at the
Myofilaments
Amelia Sumandea, Mary Garcia-Cazarin, Catherine Bozio, Gail Sievert,
C. William Balke, Marius P. Sumandea.
Efficient and specific phosphorylation of PKA substrates, elicited in response to
beta-adrenergic stimulation, require spatially confined pools of PKA anchored
in proximity of its substrates. PKA-dependent phosphorylation of cardiac sar-
comeric proteins has been the subject of intense investigations. Yet, the iden-
tity, composition, and function of PKA complexes at the sarcomeres have
remained elusive. Here we report the identification and characterization of
a novel sarcomeric AKAP (A kinase anchoring protein), cardiac troponin T
(cTnT). Using the yeast two-hybrid technology in screening two adult human
heart cDNA libraries, we identified the regulatory subunit of PKA as interacting
with human cTnT bait. Immunoprecipitation studies show that cTnT is a dual
specificity AKAP, interacting with both PKA-regulatory subunits type I and II.
The disruptor peptide Ht31, but not Ht31P (control), abolished cTnT/PKA-R
association. Truncations and point mutations identified an amphipathic helix
domain in cTnT as the PKA binding site. This was confirmed by a peptide
SPOT assay in the presence of Ht31 or Ht31P (control). Gelsolin-dependent re-
moval of thin filament proteins also reduced myofilament-bound PKA-type II.
Using a cardiac troponin (cTn) exchange procedure that substitutes the endog-
enous cTn complex with a recombinant cTn complex we show PKA-type II is
troponin-bound in the myofilament lattice. Displacement of PKA-cTnT com-
plexes correlates with a significant decrease in myofibrillar PKA activity.
Taken together, our data propose a novel role for cTnT as a dual-specificity sar-
comeric AKAP.
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Effect of Hypertrophic Cardiomyopathy Mutations on Protein-Protein
Interactions in the Thin Filament
Shannamar Dewey, Qian Xu, Susan Nguyen, Aldrin V. Gomes.
Familial hypertrophic cardiomyopathy (FHC) refers to a heterogeneous group
of cardiac diseases linked to over 630 mutations in sarcomeric proteins. Anal-
ysis of the phenotype of the associated disease, the disease outcome, and the
functional consequences of FHC mutations all indicate a complex process of
pathogenesis that cannot be predicted solely by the localization of the mutation.
However, mutations linked to HCM patients tend to increase the calcium sen-
sitivity of contraction in skinned fiber and myosin ATPase experiments. Muta-
tions linked to dilated cardiomyopathy (DCM), however, are commonly
associated with a decrease in calcium sensitivity of contraction. These general-
izations do not hold true for all FHC mutations. The process of myocardial con-
traction and relaxation also depends on complex protein-protein interactions
within the sarcomeric unit. Altered myocardial contractility resulting from dis-
turbed interaction profiles of sarcomeric proteins may play a critical role in the
pathogenesis of FHC. A few studies that have investigated protein-protein in-
teractions involving one protein with a cardiomyopathy-linked mutation show
distinct disturbances associated with HCM as compared to DCM. In this study,
we investigated the effects of several FHC linked mutations, including well-in-
vestigated mutations such as cardiac troponin T (cTnT) I79N, R278C and
F110I using a mammalian two-hybrid system. The interaction between cTnT
and alpha-tropomyosin (Tm) was significantly higher for the cTnT F110I
than wild-type cTnT. A DCM mutation has previously been shown to increase
the affinity of cTnT for Tm. cTnT I79N and R278C mutants show similar
affinity for Tm as wild-type cTnT. These results suggest that some FHC and
DCM mutations may show similar changes in cTnT-Tm interactions whileother mutations may not affect cTnT-Tm interactions. This work is partly sup-
ported by NIH grant HL096819.
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A Novel Mutation in TNNC1-ENCODED Cardiac Troponin C Predisposes
to Hypertrophic Cardiomyopathy and Recurrent Episodes of Aborted
Sudden Cardiac Death
Michelle S. Parvatiyar, Andrew P. Landstrom, Jose Renato Pinto,
Jingsheng Liang, Michael J. Ackerman, James D. Potter.
Mutations in TNNC1 are still considered uncommon causes of hypertrophic
cardiomyopathy (HCM) and linkage studies are not always available to deter-
mine inheritance. Here we report a clinical and functional characterization of
a novel TNNC1 mutation identified in a pediatric HCM patient. The proband
hosting the TNNC1 mutation was clinically evaluated including medical his-
tory, physical examination, 12-lead electrocardiogram, chest X-ray and genetic
testing. The disease presented with multiple episodes of ventricular fibrillation
and aborted sudden cardiac death. The patient demonstrated a substantial de-
gree of hypertrophy with QT prolongation. Genetic testing indicated that the
mutation was a de novo occurrence. Functional studies were performed as an-
other useful tool in establishing causation of disease. cTnC-extracted cardiac
skinned fibers were reconstituted with the cTnC-HCM mutation and increased
the Ca2þ sensitivity with no effect on the maximal force. In addition, reconsti-
tuted actomyosin ATPase assays showed that the Ca2þ sensitivity was similar
in the presence of 100% mutant cardiac Troponin C (cTnC) or 50% mutant:
50% WT cTnC. The effect of the mutation on actomyosin ATPase activation
and inhibition is currently being investigated. The Ca2þ affinity of the cTnC
mutant was evaluated by fluorescence. At all levels; troponin complex, thin fil-
ament (TF) and TF þ myosin subfragment 1 (to a lesser degree) the Ca2þ af-
finity was increased. These results suggest that this mutation has a direct affect
on the Ca2þ sensitivity of the myofilament which may alter Ca2þ handling and
contribute to the arrhythmogenesis seen in the patient. In summary, mutations
in TNNC1 may predispose to the pathogenesis of a fatal arrhythmogenic sub-
type of HCM. The underlying functional alterations of the myofilament con-
taining the mutant cTnC may further contribute to the severity of the clinical
phenotype.
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Effect of Hypertrophic Cardiomyopathy Linked Troponin C Mutations
and Troponin I Phosphorylation on the Rate of Calcium Dissociation
from the Thin Filament
Acchia Albury, Nicholas Swindle, Darl R. Swartz, Svetlana Tikunova.
The objective of this work was to investigate the effect of hypertrophic cardio-
myopathy linked A8V, E134D and D145E mutations on the rate of calcium dis-
sociation from cardiac troponin C (cTn)C on the thin filament under different
phosphorylation states of cTnI. While the E134D mutation did not affect the
rate of calcium dissociation, the A8V and D145E mutations led to significantly
slower rates of calcium dissociation from cTnC on the thin filament. The effect
of A8V, E134D and D145E mutations on the rate of calcium dissociation from
the thin filament was also examined after cTnI was replaced by either PKA
(S22D/S23DcTnI) or PKC (S41D/S43DcTnI) phosphorylation mimetic of
cTnI. Replacement of cTnI by either the PKA or PKC phosphorylation mimetic
of cTnI dramatically accelerated calcium dissociation from wild-type cTnC on
the thin filament. The A8V mutation still led to significantly slower rate of cal-
cium dissociation from cTnC on the thin filament after cTnI was replaced by
the PKA phosphorylation mimetic of cTnI. However, in the presence of PKC
phosphorylation mimetic of cTnI, the ability of A8V mutation to slow the
rate of calcium dissociation from the cTnC on thin filament was abolished.
The E134D mutation exerted minor to no effect on the rate of calcium dissoci-
ation from cTnC on the thin filament regardless of cTnI phosphorylation status.
On the other hand, the D145E mutation led to significantly slower rates of cal-
cium dissociation from cTnC on the thin filament after cTnI was replaced by
either PKA or PKC phosphorylation mimetic of cTnI. Thus, the ability of hy-
pertrophic cardiomyopathy linked cTnC mutations to affect the rate of calcium
dissociation from cTnC on the thin filament varies depending on phosphoryla-
tion status of cTnI.
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Fetal Cardiac Troponin Isoforms Rescue the Increased Ca2þ Sensitivity
Produced by a Novel Double Deletion in Cardiac Troponin T Linked to
Restrictive Cardiomyopathy
Jose Renato Pinto, Shi Wei Yang, Marc-Phillip Hitz, Michelle S. Parvatiyar,
Michelle A. Jones, Jingsheng Liang, Victor Kokta, Michelle Jaeggi,
Gregor Andelfinger, James D. Potter.
A novel double deletion in cardiac troponin T (cTnT) of two highly conserved
amino acids (N100 and E101) was found in a restrictive cardiomyopathic
(RCM) pediatric patient. Clinical evaluation revealed the presence of left atrial
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heart examined by electron microscopy revealed myofibrillar disarray and
mild fibrosis. Pedigree analysis established that this mutation arose de novo.
Functional studies were carried out in the fetal (cTnT1þ slow skeletal troponin
I (ssTnI)) and adult (cTnT3 and cardiac TnI (cTnI)) troponin (Tn) backgrounds.
The single and double cTnT mutants (cTnT3-DN100, cTnT3-DE101, cTnT3-
DN100/DE101, cTnT1-DN110, cTnT1-DE111 and cTnT1-DN110/DE111)
were generated and their functional effects analyzed in skinned cardiac muscle.
In the adult Tn enviroment, the single cTnT3-DN100 and cTnT3-DE101 muta-
tions in the presence of cTnI caused opposing changes on the Ca2þ sensitivity
of force development compared to WT with respective values of þ0.29 and
0.28 pCa units; yet the cTnT3-DN100/DE101 mutation shifted the Ca2þ sen-
sitivity to the left (þ 0.19 pCa units). In addition, cTnT3-DN100/DE101 de-
creased cooperativity of force development suggesting altered intra-filament
protein-protein interactions. In the fetal Tn eviroment, the single (cTnT1-
DN110) and double (cTnT1-DN110/DE111) deletion in the presence of ssTnI
did not show any change in the Ca2þ sensitivity compared to its control. In an
attempt to recreate the patient’s heterozygous genotype we performed a recon-
stituted ATPase activity assay. Thin filaments containing 50:50% of cTnT3-
DN100/DE101:cTnT3-WT also showed increased Ca2þ sensitivity of the
myofilament compared to the WT. This report reveals the protective role of
the Tn fetal isoforms since they rescue the increased Ca2þ sensitivity produced
by a cTnT-RCM mutation and may account for this mutation not being lethal
during gestation.
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Myofilament Tension-Cost in Guinea-Pig Single Cardiac Myofibrils
Peter N. Ayittey, Elizabeth Cruz, Pieter P. de Tombe.
We have developed a new apparatus that allows simultaneous measurement of
force activation/relaxation kinetics and ATP consumption rate in single isolated
guinea-pig cardiac myofibrils. Muscles were Ca2þ activated by rapid solution
switching as reported previously (AJP 292:R1129-1136,2007). During force
development (~10sec), the activating solution was supplemented with 0.5 mM
ribose labeled BODIPY ATP (1:10000 labeled ATP/unlabeled ATP ratio)
so as to label active cycling cross-bridges. Perfusion was rapidly switched to
activation solution without labeled ATP (<5ms). Muscle fluorescence
wasmeasured using confocal line scanning (473/538nm); force probe cantilever
position was determined by edge detection of transmitted light. The figure
shows recordings obtained in a preliminary experiment (left: slow time scale;
right: expanded for washout period). Under relaxing conditions, fluorescence
emission rapidly decayed, indicating rapid diffusional washout of labeled
ATP. In contrast, fluorescence decay was delayed in an exponential fashion in
contractions under maximal or sub-maximal contraction conditions. The rate
of fluorescent decay is proportional to cross-bridge detachment rate of the fluo-
rescently labeled myo-
sin heads and is an
index of myofilament
tension-cost. We plan
to use this new tech-
nique to determine
cross-bridge cycling
rates under steady state
and shortening condi-
tions in health and dis-
ease.
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The HCM-Associated Cardiac Troponin T Mutation K273N Accelerates
Tension Generation and Relaxation in Human Cardiac Myofibrils
Claudia Ferrara, Nicoletta Piroddi, Beatrice Scellini, Cecilia Ferrantini,
Sabine J. van Dijk, Cris dos Remedios, Chiara Tesi, Jolanda van, der Velden,
Corrado Poggesi.
In spite of extensive work on the functional sequelae of Hypertrophic Cardio-
Myopathy (HCM)-associated mutations in sarcomeric proteins, the mecha-
nisms by which the mutant proteins cause the disease have not been
definitely identified. Here we use the single myofibril technique (Tesi et al.,
Biophys. J., 2002, 83, 2142-2151) to compare the kinetics of contraction and
relaxation of myofibrils isolated from frozen left ventricular samples of one ho-
mozygous HCM patient carrying the cardiac Troponin T (cTnT) mutation
K273N (underwent heart transplantation) to those from ‘‘control’’ hearts.
Preparations, mounted in a force recording apparatus (15 C), were maximallyCa2þ-activated (pCa 4.5) and fully relaxed (pCa 9) by rapid (<10 ms) solution
switching. The rate constant of active tension generation following maximal
Ca2þ activation (kACT) was markedly faster in the myofibrils from the
K273N patient (1.7- 2 s1) compared to controls (0.7-1 s1). Replacement of
the mutant protein by exchange with wild-type recombinant human cTn re-
duced kACT of HCMmyofibrils close to control values (1 s
1). Force relaxation
kinetics upon Ca2þ removal were also faster in K273N myofibrils than in con-
trols, evidence that the apparent rate with which cross-bridges leave the force
generating states is accelerated in the HCM preparations. The results indicate
that the HCM-associated cTnT mutation K273N alters apparent cross-bridge
kinetics. This can lead to increased energy cost of tension generation that
may be central to the HCM disease process. Supported by the 7th Framework
Program of the European Union, ‘‘BIG-HEART’’ grant agreement 241577, &
Telethon-Italy GGP07133.
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The HCM-Associated Cardiac Troponin T Mutation K273N in a Human
Heart Sample Studied by in Vitro Motility Assay
Christopher Bayliss, Andrew Messer, Christobal Dos Remedios,
Jolanda Van der Velden, Steven Marston.
We isolated troponin from left ventricular muscle of a patient with a homozy-
gous K273N mutation in troponin T and compared it with troponin from donor
heart muscle using the quantitative in vitro motility assay. Motility of thin fil-
aments reconstituted with skeletal muscle actin, human tropomyosin and mu-
tant native troponin was indistinguishable from thin filaments containing
donor heart troponin (Sliding speed at 4mM Ca2þ, K273N/donor =
0.9850.09, n=9; Ca2þ- sensitivity, EC50 fraction filaments motile K273N/do-
nor = 0.9450.28, n=9).
This pattern of results was also observed with troponin from human HCMmus-
cle caused by mutations in myosin and MyBP-C and in this case it was ascribed
to a secondary modification of troponin not related to the mutation. To test for
this possibility with our K273N mutant sample, we exchanged recombinant
K273N TnT into troponin from a donor heart. In the non-HCM context the
K273N mutation caused a substantial increase in Ca2þ-sensitivity (EC50 frac-
tion filaments motile K273N/donor = 0.5450.17, n=5, p=0.004). We also ex-
changed recombinant K273N TnT into troponin from a patient with HCM due
to a mutation in MyBP-C.
We conclude that the K273N TnT mutation increases thin filament Ca2þ-sen-
sitivity, in common with other HCM-causing mutations, but in the heart muscle
of patients with HCM this effect is largely masked by secondary changes in tro-
ponin function due to post-translational modifications. We are investigating
whether troponin I phosphorylation is uncoupled from decreased Ca2þ-sensi-
tivity in this sample, since this dysfunction was observed in troponin from
HCM patients with MYH7 and MYBPC3 mutations.
Supported by Seventh Framework Program of the European Union ‘‘BIG-
HEART,’’ grant agreement 241577.
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Dynamics of Regulated Thin Filament Motility
Michael S. Carter.
The cooperative activation of regulated thin filaments (RTFs) is important for
efficient calcium handling in striated muscle. Although myosin binding to an
RTF has been proposed as a mechanism for cooperative activation, we have re-
cently shown that myosin binding constitutively rather than cooperatively acti-
vates RTFs; in other words the binding of a single myosin head fully activates
the regulatory unit of an RTF. The model predicts a well-defined relationship
between the calcium concentration at half-maximal activation (pCa50) and all
factor that influences actin-myosin attachment, katt, or detachment, kdet, kinet-
ics. To test this model, we use an in vitro motility assay to determine the effects
of altering katt and kdet on the calcium dependence of RTF sliding velocities, V.
The model accurately describes our observed changes in pCa50 when katt and
kdet are modulated with changes in [ATP] and [ADP], upon addition of inhib-
itors, and when myosin densities are varied. The model further predicts that
partially activated V result from the RTF switching between fully active and
inactive states rather than the RTF maintaining a partial level of activation.
To test this hypothesis, we are using an in vitro motility assay to measure
the dynamics of speckled fluorescent actin filaments with high spatial accuracy
and temporal resolution. Our model and data suggest that calcium sensitivity of
striated muscle is altered by changes in actin-myosin attachment and detach-
ment kinetics.
